1-7 of 7
Babatunde O. Oyajobi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A niche-dependent myeloid transcriptome signature defines dormant myeloma cells

Weng Hua Khoo, Guy Ledergor, Assaf Weiner, Daniel L. Roden, Rachael L. Terry, Michelle M. McDonald, Ryan C. Chai, Kim De Veirman, Katie L. Owen, Khatora S. Opperman, Kate Vandyke, Justine R. Clark, Anja Seckinger, Natasa Kovacic, Akira Nguyen, Sindhu T. Mohanty, Jessica A. Pettitt, Ya Xiao, Alexander P. Corr, Christine Seeliger, Mark Novotny, Roger S. Lasken, Tuan V. Nguyen, Babatunde O. Oyajobi, Dana Aftab, Alexander Swarbrick, Belinda Parker, Duncan R. Hewett, Dirk Hose, Karin Vanderkerken, Andrew C. W. Zannettino, Ido Amit, Tri Giang Phan, Peter I. Croucher
Journal: Blood
Blood (2019) 134 (1): 30–43.
https://doi.org/10.1182/blood.2018880930
Published: 2019
Includes: Supplemental data
Journal Articles

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

Michelle M. McDonald, Michaela R. Reagan, Scott E. Youlten, Sindhu T. Mohanty, Anja Seckinger, Rachael L. Terry, Jessica A. Pettitt, Marija K. Simic, Tegan L. Cheng, Alyson Morse, Lawrence M. T. Le, David Abi-Hanna, Ina Kramer, Carolyne Falank, Heather Fairfield, Irene M. Ghobrial, Paul A. Baldock, David G. Little, Michaela Kneissel, Karin Vanderkerken, J. H. Duncan Bassett, Graham R. Williams, Babatunde O. Oyajobi, Dirk Hose, Tri G. Phan, Peter I. Croucher
Journal: Blood
Blood (2017) 129 (26): 3452–3464.
https://doi.org/10.1182/blood-2017-03-773341
Published: 2017
Includes: Supplemental data
Journal Articles

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Daniel J. Dairaghi, Babatunde O. Oyajobi, Anjana Gupta, Brandon McCluskey, Shichang Miao, Jay P. Powers, Lisa C. Seitz, Yu Wang, Yibin Zeng, Penglie Zhang, Thomas J. Schall, Juan C. Jaen
Journal: Blood
Blood (2012) 120 (7): 1449–1457.
https://doi.org/10.1182/blood-2011-10-384784
Published: 2012
Includes: Supplemental data
Journal Articles

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo

Claire M. Edwards, James R. Edwards, Seint T. Lwin, Javier Esparza, Babatunde O. Oyajobi, Brandon McCluskey, Steven Munoz, Barry Grubbs, Gregory R. Mundy
Journal: Blood
Blood (2008) 111 (5): 2833–2842.
https://doi.org/10.1182/blood-2007-03-077685
Published: 2008
Journal Articles

Protein Profiling in Myeloma In Vivo ; Effects of Bortezomib in a Mouse Model of Myeloma.

Claire M. Edwards, PhD, Robert L. Caldwell, PhD, Andreia L. Bates, Jessica A. Fowler, James R. Edwards, PhD, Babatunde O. Oyajobi, MD, PhD, Seint T. Lwin, Jianghong Zhang, PhD, Gregory R. Mundy, MD
Journal: Blood
Blood (2007) 110 (11): 255.
https://doi.org/10.1182/blood.V110.11.255.255
Published: 2007
Journal Articles

Dual effects of macrophage inflammatory protein-1α on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease

Babatunde O. Oyajobi, Giovanni Franchin, Paul J. Williams, Donna Pulkrabek, Anjana Gupta, Steve Munoz, Barry Grubbs, Ming Zhao, Di Chen, Barbara Sherry, Gregory R. Mundy
Journal: Blood
Blood (2003) 102 (1): 311–319.
https://doi.org/10.1182/blood-2002-12-3905
Published: 2003
Journal Articles

Ibandronate Reduces Osteolytic Lesions but not Tumor Burden in a Murine Model of Myeloma Bone Disease

Sarah L. Dallas, I. Ross Garrett, Babatunde O. Oyajobi, Mark R. Dallas, Brendan F. Boyce, Frieder Bauss, Jiri Radl, Gregory R. Mundy
Journal: Blood
Blood (1999) 93 (5): 1697–1706.
https://doi.org/10.1182/blood.V93.5.1697
Published: 1999